Anne Samuel
Stock Analyst at JP Morgan
(1.84)
# 3,253
Out of 5,154 analysts
67
Total ratings
50%
Success rate
-2.64%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $3.40 | +105.88% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $79.96 | +57.59% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $196.06 | +47.91% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $17.62 | +41.88% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $26.07 | +130.15% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $178.50 | -0.84% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $42.25 | -14.79% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $12.08 | +131.79% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $31.54 | -33.42% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $1.93 | +573.58% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $26.58 | +1.58% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $1.22 | +309.84% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $3.40
Upside: +105.88%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $79.96
Upside: +57.59%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $196.06
Upside: +47.91%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $17.62
Upside: +41.88%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $26.07
Upside: +130.15%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $178.50
Upside: -0.84%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $42.25
Upside: -14.79%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $12.08
Upside: +131.79%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $31.54
Upside: -33.42%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $1.93
Upside: +573.58%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $26.58
Upside: +1.58%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $1.22
Upside: +309.84%